Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Molecular Partners Ag ADR
(NQ:
MOLN
)
3.880
UNCHANGED
Streaming Delayed Price
Updated: 3:34 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Molecular Partners Ag ADR
< Previous
1
2
3
4
Next >
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Molecular Partners Regains Rights To Early-Stage Cancer Asset From Amgen
April 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 10, 2022
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 30, 2022
On Tuesday, 250 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
August 29, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 29, 2022
Via
Benzinga
SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers
August 29, 2022
Citigroup raised the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $13 to $16. MacroGenics shares rose 4.8% to $3.90 in pre-market trading.
Via
Benzinga
Earnings Scheduled For August 25, 2022
August 25, 2022
Companies Reporting Before The Bell • Gold Fields (NYSE:GFI) is likely to report earnings for its first quarter. • 111 (NASDAQ:YI) is projected to report earnings for its second quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 18, 2022
We're getting ready for another full day of trading with a breakdown of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
56 Stocks Moving In Friday's Mid-Day Session
May 13, 2022
Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...
Via
Benzinga
110 Biggest Movers From Friday
May 16, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 13, 2022
Via
Benzinga
23 Stocks Moving in Friday's Pre-Market Session
May 13, 2022
Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 13, 2022
Good morning! We're starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Why Molecular Partners Shares Are Falling
April 28, 2022
Molecular Partners AG (NASDAQ: MOLN) shares are trading lower again Thursday on continued weakness after the company recently said its partner Novartis expects the FDA may require additional clinical...
Via
Benzinga
61 Biggest Movers From Yesterday
April 28, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...
Via
Benzinga
Mid-Afternoon Market Update: Extreme Networks Drops After Q3 Results; Vivakor Shares Spike Higher
April 27, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 300 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 27, 2022
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises 150 Points; NCR Shares Plunge
April 27, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 300 points on Wednesday.
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
April 27, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...
Via
Benzinga
Why Molecular Partners Shares Are Getting Hammered
April 27, 2022
Molecular Partners AG (NASDAQ: MOLN) shares are trading lower by 36.52% at $8.38 after the company and its partner Novartis expects the FDA may require additional clinical data for the Emergency Use...
Via
Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 27, 2022
It's time to dive into the world of early morning trading yet again with the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
April 27, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net...
Via
Benzinga
Molecular Partners, Novartis Note EUA For COVID-19 Therapy May Need Additional Data
April 27, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.